المؤلفون: Husain M., Birkenfeld A. L., Donsmark M., Dungan K., Eliaschewitz F. G., Franco D. R., Jeppesen O. K., Lingvay I., Mosenzon O., Pedersen S. D., Tack C. J., Thomsen M., Vilsboll T., Warren M. L., Bain S. C., BUSCEMI S

المساهمون: Husain M., Birkenfeld A.L., Donsmark M., Dungan K., Eliaschewitz F.G., Franco D.R., Jeppesen O.K., Lingvay I., Mosenzon O., Pedersen S.D., Tack C.J., Thomsen M., Vilsboll T., Warren M.L., Bain S.C., BUSCEMI S

مصطلحات موضوعية: Administration, Oral, Aged, Cardiovascular Disease, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide, Glycated Hemoglobin A, Human, Hypoglycemic Agent, Male, Middle Aged, Risk, Settore MED/49 - Scienze Tecniche Dietetiche Applicate, Settore MED/13 - Endocrinologia

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31185157; info:eu-repo/semantics/altIdentifier/wos/WOS:000484431200011; volume:381; issue:9; firstpage:841; lastpage:851; numberofpages:11; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/10447/370703Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068754660; http://www.nejm.org/medical-indexTest

الإتاحة: https://doi.org/10.1056/NEJMoa1901118Test
http://hdl.handle.net/10447/370703Test
http://www.nejm.org/medical-indexTest

المؤلفون: Ostoft, S. H., Bagger, J. I., Hansen, Torben, Pedersen, O., Faber, J., Holst, J. J., Knop, F. K., Vilsboll, T.

المصدر: Ostoft , S H , Bagger , J I , Hansen , T , Pedersen , O , Faber , J , Holst , J J , Knop , F K & Vilsboll , T 2014 , ' Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist : A Double-Blind, Randomized, Crossover Trial ' , Diabetes Care , vol. 37 , no. 7 , pp. 1797-1805 . https://doi.org/10.2337/dc13-3007Test

مصطلحات موضوعية: Adult, Aged, Blood Glucose/drug effects, Cross-Over Studies, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Fasting, Female, Glucagon-Like Peptide 1/administration & dosage, Glucagon-Like Peptide-1 Receptor, Glycated Hemoglobin A/analysis, Humans, Hypoglycemia/chemically induced, Hypoglycemic Agents/administration & dosage, Liraglutide, Male, Middle Aged, Postprandial Period, Receptors, Glucagon/agonists, Sulfonylurea Compounds/administration & dosage, Young Adult

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/900ad135-f631-4558-b600-5a3a3df0ea70Test

الإتاحة: https://doi.org/10.2337/dc13-3007Test
https://portal.findresearcher.sdu.dk/da/publications/900ad135-f631-4558-b600-5a3a3df0ea70Test

المؤلفون: Aaboe, K, Knop, F K, Vilsbøll, T, Deacon, C F, Holst, Jens Juul, Madsbad, S, Krarup, Troels Magelund

المصدر: Aaboe , K , Knop , F K , Vilsbøll , T , Deacon , C F , Holst , J J , Madsbad , S & Krarup , T M 2010 , ' Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus ' , Diabetes, Obesity and Metabolism , vol. 12 , no. 4 , pp. 323-33 . https://doi.org/10.1111/j.1463-1326.2009.01167.xTest

مصطلحات موضوعية: Adult, Aged, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Double-Blind Method, Drug Administration Schedule, Female, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Peptide YY, Postprandial Period, Pyrazines, Triazoles

الإتاحة: https://doi.org/10.1111/j.1463-1326.2009.01167.xTest
https://curis.ku.dk/portal/da/publications/twelve-weeks-treatment-with-the-dpp4-inhibitor-sitagliptin-prevents-degradation-of-peptide-yy-and-improves-glucose-and-nonglucose-induced-insulin-secretion-in-patients-with-type-2-diabetes-mellitusTest(236421d4-9c5c-444c-96f5-947d5039b8a4).html